TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways

Journal of Clinical Investigation

Volumn 117, Issue 9, 2007, Pages 2692-2701

  Haudek, Sandra B ^a   Taffet, George E ^a   Schneider, Michael D ^a   Mann, Douglas L ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c Faculty Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; FLICE INHIBITORY PROTEIN; PROTEIN BCL 2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASES; CYTOCHROMES C; ENZYME ACTIVATION; HUMANS; HYPERTROPHY; MICE; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 34848920368     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI29134     Document Type: Article

References (33)

1. Sivasubramanian, N., et al. 2001. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation. 104:826-831.
2. Bryant, D., et al. 1998. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α (TNF). Circulation. 97:1375-1381.
3. Kubota, T., et al. 1997. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-alpha. Circ. Res. 81:627-635.
4. Engel, D., Peshock, R., Armstrong, R.C., Sivasubramanian, N., and Mann, D.L. 2004. Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. Am. J. Physiol. Heart Circ. Physiol. 287:H1303-H1311.
5. Bishopric, N.H., Andreka, P., Slepak, T., and Webster, K.A. 2001. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr. Opin. Pharmacol. 1:141-150.
6. Foo, R.S., Mani, K., and Kitsis, R.N. 2005. Death begets failure in the heart. J. Clin. Invest. 115:565-571. doi:10.1172/JCI200524569.
7. Tanaka, M., et al. 2004. Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease. Blood. 104:3789-3796.
8. Dimmeler, S., Breitschopf, K., Haendeler, J., and Zeiher, A.M. 1999. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J. Exp. Med. 189:1815-1822.
9. Didenko, V.V., Tunstead, J.R., and Hornsby, P.J. 1998. Biotin-labeled haripin oligonucleotides: probes to detect double-strand breaks in DNA apopotic cells. Am. J. Pathol. 152:897-902.
10. Chang, L., et al. 2006. The E3 ubiquitin ligase itch couples JNK activation to TNF alpha-induced cell death by inducing c-FLIP(L) turnover. Cell. 124:601-613.
11. Mann, D.L., and Bristow, M.R. 2005. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation. 111:2837-2849.
12. Yussman, M.G., et al. 2002. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat. Med. 8:725-730.
13. Wencker, D., et al. 2003. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 111:1497-1504. doi:10.1172/JCI200317664.
14. Hayakawa, Y., et al. 2003. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation. 108:3036-3041.
15. Communal, C., et al. 2002. Functional consequences of caspase activation in cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A. 99:6252-6256.
16. Chang, J., et al. 2003. Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. Circulation. 108:407-413.
17. Sun, X.M., et al. 2004. Caspase activation inhibits proteasome function during apoptosis. Mol. Cell. 14:81-93.
18. Weisleder, N., Taffet, G.E., and Capetanaki, Y. 2004. Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 101:769-774.
19. Green, D.R. 2000. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 102:1-4.
20. Micheau, O., and Tschopp, J. 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 114:181-190.
21. Peter, M.E., and Krammer, P.H. 2003. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10:26-35.
22. Donovan, M., and Cotter, T.G. 2004. Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim. Biophys. Acta. 1644:133-147.
23. Zhu, L., et al. 1999. Modulation of mitochondrial Ca(2+) homeostasis by Bcl-2. J. Biol. Chem. 274:33267-33273.
24. Zhu, L., Yu, Y., Chua, B.H., Ho, Y.S., and Kuo, T.H. 2001. Regulation of sodium-calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice. J. Mol. Cell. Cardiol. 33:2135-2144.
25. Imahashi, K., Schneider, M.D., Steenbergen, C., and Murphy, E. 2004. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ. Res. 95:734-741.
26. Kirshenbaum, L.A. 2000. Bcl-2 intersects the NFkappaB signalling pathway and suppresses apoptosis in ventricular myocytes. Clin. Invest. Med. 23:322-330.
27. Hattori, R., et al. 2001. An essential role of the antioxidant gene Bcl-2 in myocardial adaptation to ischemia: an insight with antisense Bcl-2 therapy. Antioxid. Redox Signal. 3:403-413.
28. Lee, L., Irani, K., and Finkel, T. 1998. Bcl-2 regulates nonapoptotic signal transduction: inhibition of c-Jun N-terminal kinase (JNK) activation by IL-1 beta and hydrogen peroxide. Mol. Genet. Metab. 64:19-24.
29. Bradham, W.S., et al. 2002. TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling. Am. J. Physiol. Heart Circ. Physiol. 282:H1288-H1295.
30. Li, X., et al. 2000. Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation. 102:1690-1696.
31. Nemoto, S., et al. 2002. Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart. Am. J. Physiol. Heart Circ. Physiol. 282:H2316-H2323.
32. Beem, E., Holliday, L.S., and Segal, M.S. 2004. The 1.4-MDa apoptosome is a critical intermediate in apoptosome maturation. Am. J. Physiol. Cell Physiol. 287:C664-C672.
33. Baumgarten, G., et al. 2001. In vivo expression of pro-inflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J. Infect. Dis. 183:1617-1624.